Reckitt Benckiser beats earnings forecasts

World News: . []

Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic are seen in LondonLONDON (Reuters) - Reckitt Benckiser beat full-year earnings expectations as the maker of Strepsils and Mucinex benefited from an unusually heavy U.S. cold and flu season in the final quarter. Full-year adjusted earnings per share was 264.4 pence, compared to Thomson Reuters I/B/E/S estimates of 246.8 pence and a company-supplied forecast of 249 pence. An early and unusually intense flu season in North America has pushed up business for hospitals, pharmacies and the makers of tissues and cold remedies. (Reporting by Rosalba O'Brien; Editing by Paul Sandle)

Read More:

Published: .

Search for other references to "reckitt" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers